HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert Bergquist Selected Research

Ether (Diethyl Ether)

12/2004Triggering of high-level resistance against Schistosoma mansoni reinfection by artemether in the mouse model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert Bergquist Research Topics

Disease

26Schistosomiasis (Bilharziasis)
03/2022 - 05/2002
13Infections
03/2022 - 01/2002
5Reinfection
04/2020 - 05/2002
4Malaria
12/2018 - 01/2014
3Parasitic Diseases (Parasitic Disease)
05/2017 - 01/2010
2COVID-19
07/2021 - 01/2021
2Schistosomiasis japonica
10/2018 - 05/2002
2Communicable Diseases (Infectious Diseases)
05/2017 - 12/2015
2Filarial Elephantiasis (Lymphatic Filariasis)
12/2015 - 01/2014
1Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
01/2022
1Schistosomiasis mansoni
11/2021
1Neoplasms (Cancer)
10/2021
1Opium Dependence
10/2021
1Precancerous Conditions
10/2021
1Alcoholism (Alcohol Abuse)
10/2021
1Colonic Neoplasms (Colon Cancer)
04/2021
1Colorectal Neoplasms (Colorectal Cancer)
04/2021
1Autoimmune Diseases (Autoimmune Disease)
10/2018
1Chronic Bronchitis
08/2018
1Brucellosis (Malta Fever)
11/2017
1Q Fever (Fever, Q)
11/2017
1Rabies (Hydrophobia)
11/2017
1Fascioliasis
11/2017
1Rift Valley Fever
11/2017
1Buruli Ulcer
11/2017
1Neglected Diseases
11/2017
1Onchocerciasis
12/2015
1Granuloma
09/2010

Drug/Important Bio-Agent (IBA)

11VaccinesIBA
01/2021 - 05/2002
7Pharmaceutical PreparationsIBA
01/2020 - 05/2002
6Praziquantel (Biltricide)FDA Link
04/2020 - 10/2010
5AntigensIBA
12/2018 - 05/2002
4ArtemetherFDA Link
12/2018 - 01/2002
3Antimalarials (Antimalarial Agents)IBA
01/2014 - 01/2002
2Indicators and Reagents (Reagents)IBA
05/2021 - 04/2017
2artemisinin (artemisinine)IBA
12/2018 - 12/2015
2CytokinesIBA
10/2003 - 05/2002
1MutL Protein Homolog 1IBA
01/2022
1Nucleic AcidsIBA
11/2021
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
10/2021
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
10/2021
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
07/2021
1SeleniumIBA
04/2021
1CobaltIBA
04/2021
1Environmental Pollutants (Pollutants, Environmental)IBA
04/2021
1Heavy MetalsIBA
04/2021
1CopperIBA
04/2021
1Complement System Proteins (Complement)IBA
01/2019
1APTIBA
12/2018
1Interleukin-12 (IL 12)IBA
10/2018
1Antinuclear AntibodiesIBA
10/2018
1InterleukinsIBA
10/2018
1Interleukin-17 (Interleukin 17)IBA
10/2018
1Coal (Coals)IBA
08/2018
1Biological ProductsIBA
11/2017
1Inosine Diphosphate (IDP)IBA
05/2017
1EmulsionsIBA
01/2016
1glucopyranosyl lipid-AIBA
01/2016
1Ivermectin (Mectizan)FDA Link
12/2015
1avermectinIBA
12/2015
1AntibodiesIBA
01/2015
1AnthelminticsIBA
10/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2010
1SolutionsIBA
01/2010
1Coloring Agents (Dyes)IBA
11/2005
1artenimol (dihydroartemisinin)IBA
12/2004
1Ether (Diethyl Ether)IBA
12/2004

Therapy/Procedure

10Drug Therapy (Chemotherapy)
01/2021 - 05/2002
3Therapeutics
12/2018 - 01/2014
1Aftercare (After-Treatment)
03/2022
1Mass Drug Administration
07/2015